Marvell Technology, Inc. Work in process increased by 3.6% to $765.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.9%, from $643.90M to $765.50M. Over 4 years (FY 2022 to FY 2026), Work in process shows an upward trend with a 10.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $383.31M | $372.05M | $516.65M | $578.90M | $661.80M | $707.70M | $734.30M | $756.30M | $668.20M | $632.70M | $579.90M | $523.80M | $527.10M | $584.90M | $643.90M | $709.00M | $739.00M | $738.60M | $765.50M |
| QoQ Change | — | -2.9% | +38.9% | +12.0% | +14.3% | +6.9% | +3.8% | +3.0% | -11.6% | -5.3% | -8.3% | -9.7% | +0.6% | +11.0% | +10.1% | +10.1% | +4.2% | -0.1% | +3.6% |
| YoY Change | — | — | — | — | +72.7% | +90.2% | +42.1% | +30.6% | +1.0% | -10.6% | -21.0% | -30.7% | -21.1% | -7.6% | +11.0% | +35.4% | +40.2% | +26.3% | +18.9% |
| % of Inventories | 71.2% | 81.0% | 82.2% | 80.4% | 79.2% | 77.5% | 76.7% | 70.8% | 65.1% | 62.3% | 61.6% | 60.6% | 63.8% | 71.5% | 74.9% | 68.9% | 69.0% | 70.2% | 75.5% |
| Share Change | — | +9.7pp | +1.2pp | -1.8pp | -1.2pp | -1.7pp | -0.8pp | -5.9pp | -5.7pp | -2.8pp | -0.7pp | -1.0pp | +3.2pp | +7.7pp | +3.4pp | -6.1pp | +0.1pp | +1.3pp | +5.2pp |
We use cookies for analytics. See our Privacy and Cookie Policy.